1
Clinical Trials associated with 124I-CPD-1023-figitumumabA Phase 1a, Multi-centre, Open-label, Non-randomized Study to Assess the Safety, Biodistribution and Tumour Uptake of [I-124]-CPD-1028 Injection
The purpose of the study is to evaluate the safety and biodistribution of [I-124]-CPD-1028 Injection in cancer patients with solid tumours.
100 Clinical Results associated with 124I-CPD-1023-figitumumab
100 Translational Medicine associated with 124I-CPD-1023-figitumumab
100 Patents (Medical) associated with 124I-CPD-1023-figitumumab
100 Deals associated with 124I-CPD-1023-figitumumab